Pharmaceutical Product Development News

Eli Lilly and Co $ 35.39 Change -1.18 -3.21% Volume 11.39m LLY /quotes/comstock/10t!drg.x Nyse Arca Pharmaceutical 309.82 Change +1.72 +0.56% Volume 0.00 $DRG /quotes/comstock/10t!btk.x Nyse Arca Biotechnology Inde 914.66 Change +5.59 +0.61% Volume 0.00 $BTK Kiosk Intraday data provided by Interactive Data Real Time Services , a division of ...

Offering regional and national programs, CIO events bring together some of the most respected names and thought leaders in information technology and security.

PORT DEPOSIT, Md.-- --Artesian Water Maryland, a subsidiary of Artesian Resources Corporation , announced today that it has entered into an agreement to purchase the water... WILMINGTON, N.C.-- --PPD, Inc.

SYDNEY, Australia, Dec. 3, 2009-Pharmaceutical company Pharmaxis today announced significant headline results for the second six month dosing of its international Phase III trial of Bronchitol in people with cystic fibrosis.

Click Here Now Ita s Foolanthropy season again, when we at Fool HQ band together with you, our readers, and support inspiring causes.

Drug development contractor Pharmaceutical Product Development Inc. said Monday it completed a $77 million buyout of BioDuro LLC.

C. Ronald Bilowith, 71, of Ocean View, formerly of Clifton, N.J., died Sunday, Nov.

Sydney, NSW, November 20, 2009 -- Pharmaceutical wholesaler Leopold Fiebig has now fully implemented the IBS Pharma for its industry-specific, highly customized financial accounting processes which, as a result, are now completely integrated with the entire business.

In late October, when PPD, Inc. acquired fellow CRO Excel PharmaStudies, we suggested more CRO consolidation might follow.

PPD Inc. said Tuesday that it has signed a deal with Belgian drug-maker Janssen Pharmaceutica N.V. to take two developmental compounds through Phase II trials and possibly to market.

Drug development contractor Pharmaceutical Product Development Inc. said Wednesday it will buy BioDuro LLC in a move to expand capabilities in China.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

PPD, Inc. today announced it has entered an agreement with Janssen Pharmaceutica N.V. to develop and commercialize two Phase II-ready therapeutic compounds, one to treat diarrhea-predominant irritable bowel syndrome and the other to treat complicated skin and skin structure and respiratory infections.

Ore Pharmaceutical Holdings Inc. today reported financial results and provided an operational update for the third quarter ended September 30, 2009.

I've been critical of pharma's claims that developing countries are going to save them from the inevitable patent cliffs.

PPD, Inc. today announced its board of directors declared a cash dividend for the fourth quarter of 2009 under its annual cash dividend policy.

Takeda Pharmaceutical Co., Asia's biggest drugmaker, sued Teva Pharmaceutical Industries Ltd., alleging infringement of a U.S. patent for the insomnia treatment Rozerem.

PPD, Inc. today announced it has completed its acquisition of Excel PharmaStudies, Inc., the market leader and one of the largest contract research organizations in China.

Is consolidation the new theme in China's fragmented CRO sector? Over the past five to ten years, an almost bewildering array of new CROs has sprung into existence.

Pharmaceutical Product Development plans to spin off its drug development business and capitalize it with $100 million.